Study examined CD79B mutation as a prognostic biomarker in DLBCL.
Home / Resource Library / The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review
Study examined CD79B mutation as a prognostic biomarker in DLBCL.